US launches Section 301 probe into Germany over drug pricing
The US has launched an investigation under Section 301 of the Trade Act of 1974 against Germany over alleged underpayment for innovative pharmaceutical products.
- Country:
- United States
The United States has initiated an investigation under Section 301 of the Trade Act of 1974 against Germany, U.S. Trade Representative Jamieson Greer said on Thursday.
The investigation will seek to determine whether persistent underpayment for innovative pharmaceutical products by Germany is unreasonable or discriminatory, the USTR said.
ALSO READ
-
Trump and Xi Set for High-Stakes Summit: Trade, Taiwan, and Technology in Focus
-
US Tariff Announcement Delay Amidst Xi-Trump Summit
-
Reclaiming National Pride: Klopp’s Call for 'Positive Patriotism'
-
Raiffeisen's Russian Dilemma: A Financial Linchpin Under Fire
-
Raiffeisen Bank Faces Renewed Scrutiny Over Russian Trade Allegations
Google News